Cargando…

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

Detalles Bibliográficos
Autores principales: Abd El-Aziz, Tarek Mohamed, Al-Sabi, Ahmed, Stockand, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607365/
https://www.ncbi.nlm.nih.gov/pubmed/33144565
http://dx.doi.org/10.1038/s41392-020-00374-6
_version_ 1783604636744155136
author Abd El-Aziz, Tarek Mohamed
Al-Sabi, Ahmed
Stockand, James D.
author_facet Abd El-Aziz, Tarek Mohamed
Al-Sabi, Ahmed
Stockand, James D.
author_sort Abd El-Aziz, Tarek Mohamed
collection PubMed
description
format Online
Article
Text
id pubmed-7607365
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76073652020-11-03 Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19 Abd El-Aziz, Tarek Mohamed Al-Sabi, Ahmed Stockand, James D. Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-11-03 /pmc/articles/PMC7607365/ /pubmed/33144565 http://dx.doi.org/10.1038/s41392-020-00374-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Highlight
Abd El-Aziz, Tarek Mohamed
Al-Sabi, Ahmed
Stockand, James D.
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title_full Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title_fullStr Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title_full_unstemmed Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title_short Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19
title_sort human recombinant soluble ace2 (hrsace2) shows promise for treating severe covid­19
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607365/
https://www.ncbi.nlm.nih.gov/pubmed/33144565
http://dx.doi.org/10.1038/s41392-020-00374-6
work_keys_str_mv AT abdelaziztarekmohamed humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19
AT alsabiahmed humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19
AT stockandjamesd humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19